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Anhedonia and Ambivalence in Schizophrenic Patients 
with Fronto-Cerebellar Metabolic Abnormalities:  
A Fluoro-D-Glucose Positron Emission Tomography Study 
 
 
 
ObjectiveaaPrefrontal and cerebellar abnormalities have been associated with higher cogni-
tive deficits in schizophrenia. The current study aimed to show whether or not schizophrenic 
patients with fronto-cerebellar functional abnormalities show more anhedonia or ambivalence.
MethodsaaRegional cerebral metabolic activity was measured using fluoro-D-glucose posi-
tron emission tomography and was compared between 24 patients with chronic schizophre-
nia and 22 healthy normal volunteers. The existence of regional prefrontal hypofunction and 
regional cerebellar hyperfunction was investigated in each patient. Demographic and clinical 
variables including the emotional self-report scales were compared between the subgroups of 
the patients categorized according to the existence and the absence of the regional dysfunc-
tions. 
ResultsaaComparisons between each patient and the total normal controls revealed that 
14 of the total twenty-four patients had regional hypofrontal functions, whereas 11 patients 
had regional hypercerebellar functions. Patients with prefrontal hypofunction showed more 
severe anhedonia than those without prefrontal hypofunction, whereas patients with cerebel-
lar hyperfunction compared to those without cerebellar hyperfunction had more severe am-
bivalence. 
ConclusionaaIt seems that fronto-cerebellar abnormalities may be associated with car-
dinal emotional features of schizophrenia, such as anhedonia and ambivalence. 
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Introduction 
 
Schizophrenia is a debilitating disease with heterogeneous phenomenology and di-
verse symptoms.
1 Among the variety of symptoms, both anhedonia and ambivalence 
are considered to be fundamental in patients with schizophrenia.
2 Anhedonia is defin-
ed as a deficit in the ability to experience pleasant emotions, and ambivalence refers
to a state of simultaneous and conflicting emotional valences toward a person or ob-
ject.
2 Therefore, the two symptoms could reflect some aspects of emotional distur-
bances that accompany schizophrenia. 
However, patients with schizophrenia have a deficit in the ability to experience posi-
tive emotions related to future activities (anticipatory pleasure) but experience normal 
levels of positive emotions when directly engaged in pleasant activities (consummatory 
pleasure).
3 This indicates that anhedonia may be caused by the disturbances in higher
cognitive functioning, e.g. executive functions such as anticipation as well as emotion-
al processing. In addition, ambivalence essentially induces approach-avoidance con-
flicts and thus higher cognitive functions are required to resolve conflicting emotional
valences.
4 Emotional disturbances in individuals with schizophrenia are thought to de- 
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rive from abnormal interactions between the mesolimbic 
system and brain regions such as the prefrontal cortex and 
cerebellum that are responsible for higher cognitive func-
tions.
5,6 Therefore, the psychological and neural underpin-
nings of these two fundamental symptoms could be based 
on the interface between the neural substrates of emotion 
and higher cognition.   
The prefrontal cortex and the cerebellum in the hu-
man are two brain regions that are massively larger by 
approximately one-third when compared to primates that 
lack capacities for higher cognitive functions.
7 In addi-
tion, tract-tracing studies show that the cerebellum has 
strong connectivity between the prefrontal regions, which 
supports the notion that the cerebellum participates in 
neural circuits that perform higher cognitive functions 
of the prefrontal cortex.
8 Therefore, the prefrontal cortex 
and the cerebellum are among a variety of brain regions 
considered to be key substrates for higher cognitive func-
tions.
6,9 
Abnormalities in higher cognitive functions, hallmarks 
of schizophrenia, have been consistently connected to dis-
rupted functioning of the prefrontal cortex and the cerebel-
lum.
9-12 Thus, the aim of this study was to examine wheth-
er patients with dysfunctional activity in these brain re-
gions would show more severe anhedonia or ambivalence 
than subjects with normal activity at the same loci.   
Abnormalities in higher cognitive functions in schizo-
phrenia are associated with prefrontal hypofunction rather 
than hyperfunction, and cerebellar hypofunction
10,13 or hy-
perfunction.
9,14 The crucial roles of the cerebellum in the 
circuit responsible for higher cognitive functions are coor-
dinating or modulating the activities in the prefrontal cor-
tex, and therefore cerebellar activities could vary across 
features of required higher cognitive functions. Moreover, 
it is very difficult to connect a regional abnormality pat-
tern to a specific clinical symptom in each individual pa-
tient, as most imaging results in schizophrenia have been 
obtained from analyzing the between-group differences 
or the within-group correlations. This is in part due to 
diverse functional patterns among individual patients with 
the illness as well as subtle variations in functional acti-
vities in the individuals.   
Therefore, we investigated abnormal regional brain 
functions using 2-deoxy-2-18F-fluoro-glucose-positron 
emission tomography (18F-FDG-PET) in each individual 
patient when compared with total normal controls in order 
to predict those who would have abnormal functions in the 
prefrontal cortex and the cerebellum. We then compared the 
severities of anhedonia and ambivalence between patients 
with and without prefrontal hypofunction, and between 
patients with and without cerebellar hyperfunction. We 
hypothesized that the severities of anhedonia and ambi-
valence would be significantly different between the pa-
tient subgroups. 
 
Methods 
 
Subjects 
The subjects were 24 patients with schizophrenia and 
22 age-matched normal, healthy volunteers. The patients 
were recruited from the outpatient clinics at the Severance 
Mental Health Hospital (SMH), and had been in follow-
up for more than two years. They fulfilled the DSM-IV cri-
teria for schizophrenia, as diagnosed using the Structured 
Clinical Interview for DSM-IV (SCID).
15 The exclusion 
criteria for the study were any lifetime history of neurolo-
gical or other significant medical illnesses and any past his-
tory of substance abuse. The normal, healthy volunteers 
were recruited from the local community, and were scre-
ened for any current or lifetime history of a DSM-IV Axis 
I disorder using the SCID. The study was carried out under 
the guidelines established by the institutional review board 
of the SMH for research involving human subjects, and 
written informed consent was obtained from all subjects 
before the study began. 
Each group contained the same number of men and wo-
men, and all participants were right-handed. The mean 
ages of the patient and normal control groups were 30.5 
years (SD=3.5, range=23-36) and 30.3 years (SD=3.1, 
range=25-35), respectively. The mean years of education 
were 12.8 (SD=2.0) and 13.0 years (SD=1.6), respectively. 
Age and educational background were not significantly 
different between the groups. At the time of positron emis-
sion tomography (PET) scanning, the mean duration of ill-
ness in the patient group was 8.4 years (SD=3.8). All pa-
tients received either one or two neuroleptics, including 
risperidone, olanzapine, clozapine, aripiprazole and halo-
peridol, with a mean chlorpromazine- equivalent dose
16 of 
586.4 mg (SD=349.5). 
 
Measurement of symptom severity and  
emotional characteristics 
Symptom severity of the patients was assessed using 
the Positive and Negative Syndrome Scale
17 within the 
week before PET scanning. The mean scores of schizo-
phrenic symptom severities were calculated in the patient 
group: positive (mean=16.1, SD=3.2), negative (mean= 
17.0, SD=2.4), general (mean=34.0, SD=4.9), and total 
(mean=67.1, SD=8.9) symptoms.   
Immediately after PET scanning, all subjects reported 
their own emotional tendencies by filling out four different 
self-report scales such as the physical and social anhedonia 
scales,
18 the schizotypal ambivalence scale
19 and the emo-
tional expressivity scale.
20 The physical anhedonia scale  
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consists of 61 Yes-No questions and measures a deficit 
in the ability to experience pleasure, whereas the social 
anhedonia scale containing 40 items measures social with-
drawal, a lack of interest and pleasure in social and inter-
personal relationships. Scores of the physical anhedonia 
scale in the patients (mean=21.3, SD=9.6) were higher 
than those in the normal controls (mean=14.5, SD=6.9)(t= 
2.74, p<0.01), and scores of the social anhedonia scale in 
the patients (mean=15.5, SD=6.2) were also higher than 
those in the normal controls (mean=9.2, SD=5.1)(t=3.77, 
p<0.001). The schizotypal ambivalence scale consists of 
19 Yes-No questions to identify ambivalence as character-
istic of schizotypy and schizophrenia. Scores of the schi-
zotypal ambivalence scale in the patients with schizophre-
nia (mean=10.6, SD=6.3) were higher than those in the 
normal controls (mean=6.2, SD=3.7)(t=2.95, p<0.01). The 
emotional expressivity scale, a 17-item 6-point scale, as-
sesses the extent to which people outwardly display their 
emotions. Unlike other scales, scores of the emotional ex-
pressivity scale in the patients (mean=60.6, SD=8.6) were 
not significantly different from those in the normal controls 
(mean=65.6, SD=10.7). The demographic and scales data 
were analyzed using the Statistical Package for the Social 
Sciences (SPSS)(Version 13.0, Chicago, IL, USA) and the 
significance was set at p<0.05 (two-tailed).  
 
Positron emission tomography procedures and 
imaging data preprocessing   
PET images were acquired using a GE ADVANCE PET 
scanner (GE, Milwaukee, Wisconsin, USA) which had an 
intrinsic resolution of 4.8 mm full width at half maximum 
(FWHM) and a slice thickness of 4.25 mm for a longitu-
dinal field of view of 15.2 cm. Subjects were asked to lie 
still with their eyes closed in a quiet, dimly lit room for 
40 minutes after receiving an intravenous injection of ap-
proximately 185 MBq (5 mCi) of 
18F-FDG. Afterwards, 
an 8-min transmission scan was performed using Ge-68 
rod sources to correct for attenuation. The emission scan 
continued in 3-dimensional mode for 15 minutes. Gather-
ed data were then reconstructed in a 128×128×35 ma-
trix with a pixel size of 1.95×1.95×4.25 mm using a 3-di-
mensional filtered back-projection algorithm employing 
a transaxial 8.5 mm Hanning Filter and an 8.5 mm axial 
Ramp Filter.
21 
Spatial pre-processing and statistical analyses were 
performed using Statistical Parametric Mapping (SPM2, 
Institute of Neurology, University College of London, UK). 
All reconstructed images were spatially normalized into 
the MNI (Montreal Neurological Institute, McGill Univer-
sity, CA) standard PET template to remove the inter-sub-
ject anatomical variability. An affine transformation was 
performed to determine the 12 optimal parameters in order 
to register the brain on the template. Subtle differences 
between the transformed image and the template were 
removed by the nonlinear registration method using the 
weighted sum of the pre-defined smooth basis functions 
involved in discrete cosine transformation. Spatially nor-
malized images were smoothed by convolution with an 
isotropic Gaussian kernel with 14 mm FWHM to increase 
the signal-to-noise ratio and accommodate for variations 
in subtle anatomical structures. 
 
Statistical analysis  
The effects of global metabolism were removed by nor-
malizing the count of each voxel to the mean count of the 
brain (proportional scaling in SPM). In order to demon-
strate abnormalities in each case, comparisons were made 
between each patient and the 22 total normal controls. Sig-
nificant decreases and increases of the adjusted regional 
cerebral metabolism were obtained using t-statistics at 
every voxel. To facilitate interpretation, the t-values were 
transformed to Z-scores in the standard Gaussian distribu-
tion. The clusters consisting of a minimum of 50 contigu-
ous voxels with the threshold of an uncorrected p<0.001 
were considered to be significant. According to the a pri-
ori hypothesis that there would be prefrontal hypofunction 
and cerebellar hyperfunction in patients with schizophre-
nia, the existence or the absence of regional abnormal 
clusters in the prefrontal cortex and in the cerebellum were 
categorized into subgroups using the Talaraich coordinate 
system.
22 Thereafter, demographic and clinical variables 
were compared between these defined subgroups using 
χ2-tests for categorical variables or independent t-tests for 
continuous variables. We used the Statistical Package 
for the Social Sciences (SPSS) (Version 13.0, Chicago, IL, 
USA), and significance of the differences was accepted 
when p<0.05 (two-tailed) in the analyses. 
 
Results 
 
As demonstrated in Table 1, comparisons between each 
patient and the total normal controls revealed that 14 of 
TABLE 1. Existence or absence of regional hypofrontal and hypercerebellar functions in an individual patient with schizophrenia when com-
pared with the normal comparison group 
Case number  1  2  3 4 5 6  7  8  9  10  11  12  13  14  15  16  17 18 19 20 21 22  23  24 
Hypofrontal functions  +  +  +  +  o  +  o  +  +  o  +  o  o  o  o  +  o  +  +  o  +  +  +  o 
Hypercerebellar functions  o  o  o  +  +  o  +  +  o  +  o  +  o  o  o  +  +  o  o  o  +  +  +  o 
+: existence, o: absence.  
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the total twenty-four patients had regional hypofrontal 
functions, and 11 patients had regional hypercerebellar 
functions. Six patients had both regional hypofrontal and 
hypercerebellar functions, 8 patients had only regional 
hypofrontal functions, and 5 patients had only regional 
hypercerebellar functions. However, 5 patients had no ab-
normalities in these brain regions. 
Table 2 shows subgroup means of demographic and 
clinical variables according to whether or not the regional 
metabolic abnormalities were apparent. Most variables 
were unchanged whether or not abnormal functioning was 
evident. As shown in Figure 1, the only difference between 
the patient subgroups with and without regional hypofron-
tal function was observed in the physical anhedonia scale. 
On the other hand, the only difference between the patient 
subgroups with and without regional hypercerebellar func-
tion was identified in the schizotypal ambivalence scale. 
 
Discussion 
 
Our unique approach, in which each case and the total 
normal controls were compared, demonstrated that only 
6 patients (25.0%) had both regional hypofrontal and hy-
percerebellar functions, whereas 5 patients (20.8%) had 
no abnormalities in these brain regions. It is well known 
that schizophrenia is a heterogeneous disorder. Previous 
studies have reported inconsistent brain activities in pa-
tients with schizophrenia during the resting state and even 
during the task-stimulating condition.
23,24 As described 
in Table 1, regional activity patterns are variable among 
the patients, suggesting that results from the group com-
parison could be dependent on the composition of subjects. 
Therefore, the abnormalities in the two brain regions 
could not be generalized to problems of all patients with 
schizophrenia, but rather associated with some critical 
features rather than common problems in the patients 
with schizophrenia. 
The patients with prefrontal hypofunction compared 
to those without prefrontal hypofunction showed more se-
vere physical anhedonia, whereas the patients with cere-
bellar hyperfunction relative to those without cerebellar 
hyperfunction exhibited more severe ambivalence (Table 2, 
Figure 1). These results could suggest that the two symp-
toms have different neural correlates within the brain such 
as prefrontal-thalamic-cerebellar circuitry.
25 
In fact, patients with schizophrenia had a normal in-
ternal experience of positive emotion in the moment (con-
summatory pleasure), but they failed to anticipate or ex-
TABLE 2. Subgroup means (SD) of demographic and clinical variables
Hypofrontal functions  Hypercerebellar functions 
 
Existent (N=14) Absent  (N=10) Existent  (N=11) Absent  (N=13) 
Age (years)  031.2 (3.4)  029.4 (3.7)  030.4 (3.4)  030.5 (3.8) 
Sex (male/female)  8/6 4/6 7/4 5/8 
Education (years)  012.7 (1.5)  012.8 (2.7)  012.0 (1.9)  013.4 (1.9) 
Duration of illness (years)  008.4 (3.3)  008.4 (4.5)  010.0 (4.4)  007.0 (2.6) 
Chlorpromazine equivalent dose (mg) 655  (415) 490  (215) 591  (337) 583  (374) 
P A N S S       -  P o s it i ve   016.6 (3.2)  015.3 (3.2)  016.8 (2.4)  015.5 (3.7) 
- Negative  017.1 (2.2)  016.9 (2.8)  017.7 (2.3)  016.4 (2.4) 
- General  033.6 (5.1)  034.6 (4.8)  035.3 (4.9)  032.9 (4.8) 
- Total  067.3 (8.4)  066.8 (10.1)  069.8 (9.2)  064.8 (8.3) 
Physical anhedonia scale  024.8 (10.1)*  016.3 (6.5)  024.9 (12.3)  018.2 (5.3) 
Social anhedonia scale  016.6 (7.0)  013.9 (4.7)  017.6 (7.5)  013.7 (4.4) 
Schizotypal ambivalence scale  011.0 (6.1)  010.1 (6.8)  013.3 (6.4)*  008.4 (5.4) 
Emotional expressivity scale  058.9 (6.1)  063.1 (11.1)  058.4 (7.4)  062.5 (9.4) 
*p<0.05. PANSS: positive and negative syndrome scale 
 
10
Existence    Absence 
20
30
40
5
10
15
20
Existence    Absence 
Frontal hypofunctions  Cerebellar hypofunctions 
Physical Anhedonia Scale  Schizotypal Ambivalence Scale 
FIGURE 1. Differences of the physical anhedonia scale scores
and schizotypal ambivalence scale scores between the existence
and the absence of the regional hypofrontal and hypercerebellar
functions.  
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pect that future events would elicit these emotions (anti-
cipatory pleasure).
3 Behavioral studies indicated deficits 
in reward-related decision-making in patients with schiz-
ophrenia,
26 and neuroimaging studies suggested that they 
failed to recruit reward-related brain regions while predi-
cting future reward.
27-30 Moreover, a recent study
31 showed 
that they were impaired in amplification but not suppres-
sion of pleasant expressions. These results could suggest 
that hypofunction of the brain regions responsible for 
the anticipation of future pleasant activities is a critical 
neural substrate of anhedonia. It is well-established that 
the prefrontal cortex among various brain areas plays key 
roles in anticipation;
32 in particular, the prefrontal cortex 
may be preferentially engaged in the positive emotions.
33 
Furthermore, the hypofrontality of schizophrenia is asso-
ciated with impairments in executive functions such as 
anticipation.
32 These findings our consistent with our re-
sults that patients with prefrontal hypofunction have more 
severe anhedonia than those without prefrontal hypofunc-
tion .   
On the other hand, core roles of the cerebellum in the 
higher cognitive functions include rapid, online error de-
tection, modulation, and coordination, culminating in the 
production of mental representations in a fine-tuned pat-
tern. The cerebellum is activated in a variety of mental 
activities including facial recognition, emotional attribu-
tion, theory of mind, directed attention and many types of 
memory.
6 In order to resolve ambivalence by simultane-
ously representing conflicting emotional valences,
4 indivi-
duals may have to detect the errors driven from the con-
flicting emotional representations, modulate and coordinate 
the representations and the errors in a rapid and online 
manner, and then produce the integrated mental represen-
tations in a fine-tuned pattern. Therefore, it may be pos-
sible that hyperfunction of the cerebellum may reflect 
enhanced difficulty in resolution of ambivalence. This 
possibility could be supported by our finding indicating 
that the patients with cerebellar hyperfunction have more 
severe ambivalence than those without cerebellar hyper-
function.  
A limitation of our study was that the patients with 
schizophrenia were all medicated with antipsychotics. 
There are reports that antipsychotic medications affect 
cerebellar and even prefrontal functions.
34,35 However, it 
has to be emphasized that both prefrontal hypofunction 
and cerebellar hyperfunction were found in drug-naїve 
first-episode patients with schizophrenia.
14 Another caveat 
is that we used self-report scales to measure the emotion-
al tendencies. Because of the problem of low reliability 
in the scales, it is possible that the exact emotional states 
of the subjects were not reflected. Another limitation is 
that our major findings were obtained from the compar-
isons between patient subgroups, and there were only a 
small number of subjects in each patient subgroup. In ad-
dition, the validity of our approach, in which each case 
and the total normal controls were compared, might need 
to be confirmed by future investigations, though it was 
used only to set up the patient subgroups.   
In conclusion, this study found that the patients with 
prefrontal hypofunction tended to have more severe anhe-
donia than those without prefrontal hypofunction, whereas 
the patients with cerebellar hyperfunction tended to show 
more severe ambivalence than those without cerebellar 
hyperfunction. Therefore, these results support the notion 
that prefronto-cerebellar abnormalities are associated with 
cardinal features of schizophrenia, such as anhedonia and 
ambivalence. 
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